What is the current Price Target for the Virpax Pharmaceuticals Inc stock?

The average Virpax Pharmaceuticals Inc target price is $3.06. This is 871.43% higher than the current stock price. The highest price target is 900.00%, the lowest is 861.90%. 3 Analysts have issued a price target Virpax Pharmaceuticals Inc 2026 .

How high will the Virpax Pharmaceuticals Inc stock rise?

No reliable answer can be given as to how high the Virpax Pharmaceuticals Inc stock will rise. The performance of stocks, including the Virpax Pharmaceuticals Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Virpax Pharmaceuticals Inc stock today?

The performance of Virpax Pharmaceuticals Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Virpax Pharmaceuticals Inc stock fall?

The decline in Virpax Pharmaceuticals Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Virpax Pharmaceuticals Inc Forecast, price target & analysts

$0.30

1.83% yesterday

Nasdaq, Jun 27, 05:43 pm CET

ISIN

US9282511073

Symbol

VRPX

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health

Industry

Pharmaceuticals

Overview Dividends Analysts Charts News Strategies

Virpax Pharmaceuticals Inc Target price 2025 - Analyst rating & recommendation

Virpax Pharmaceuticals Inc Classifications & Recommendation:

Hold

50%

Sell

50%

Virpax Pharmaceuticals Inc Price Target

Target Price	$3.06
Price	$0.32
Potential	871.43% register free of charge
Number of Estimates	3

	3 Analysts have issued a price target Virpax Pharmaceuticals Inc 2026 . The average Virpax Pharmaceuticals Inc target price is $3.06. This is 871.43% register free of charge higher than the current stock price. The highest price target is $3.15 900.00% register free of charge , the lowest is $3.03 861.90% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend Virpax Pharmaceuticals Inc to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Virpax Pharmaceuticals Inc stock has an average upside potential 2026 of 871.43% register free of charge . Most analysts recommend the Virpax Pharmaceuticals Inc stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2030

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-2.84	-15.81
	78.10%	456.69%
P/E		negative

3 Analysts have issued a Virpax Pharmaceuticals Inc forecast for earnings per share. The average Virpax Pharmaceuticals Inc EPS is

Unlock

. This is

Unlock

than earnings per share in the financial year 2024. The highest EPS forecast is

Unlock

, the lowest is

Unlock

This results in the following potential growth metrics and future valuations:

2024	$-2.84	78.10%
2025	$-15.81 456.69% Unlock
2026	$-12.75 19.35% Unlock
2027	$-13.52 6.04% Unlock
2028	$-14.75 9.10% Unlock

Current	-0.24	73.26%
2025	-0.02 91.75% Unlock
2026	-0.02 0.00% Unlock
2027	-0.02 0.00% Unlock

Virpax Pharmaceuticals Inc...

Current Virpax Pharmaceuticals Inc Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more

Analyst	Rating	Action	Date
Maxim Group	Locked ➜ Locked	Locked	Oct 09 2024

Analyst Rating	Date
Locked Maxim Group: Locked ➜ Locked	Oct 09 2024

Discover more stocks with a high price target

Berkshire Hathaway 154,261.00%

Alibaba Group Holding Ltd 1,077.45%

BioNTech SE - ADR 31.42%

Tencent Holdings Ltd. 26.26%

Adyen 24.86%

Deutsche Telekom 24.51%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now